Article originally published on Global Banking & Finance Review, May 2022.

According to a UK government report, two in five businesses in Britain suffered cybersecurity attacks in the 12 months to March 2021, with an attached cost of £13,400 on average per data breach for medium and large companies.

The report suggests that the Q1’22 results for most of the banks in the UAE highlighted an increase in profitability, despite lower non-interest income.

Leading global professional services firm Alvarez & Marsal (A&M) appointed Dr. Chan Yoo as a Managing Director in its Seoul, South Korea, office. Dr. Yoo’s hire links his extensive transformation experience with Asian manufacturing corporations across multiple industries to A&M’s strategic growth plans in support of the market’s needs.

Global Transaction Advisory Group Managing Director and Global Practice  Leader, Paul Aversano, was quoted in a recent article in Axios, “Deconstructing the Dissidents.”

Global professional services firm Alvarez & Marsal (“A&M”) today announces the findings of its latest analysis and predictor of shareholder activism in Europe in 2022, the “A&M Activist Alert”, or “AAA”.

Alvarez & Marsal (A&M), has appointed Alfonso A-Pallete to lead A&M Taxand’s Miami-based Latin America Complex Transactions group.

Whilst the world runs from one crisis to another crisis, the M&A market is still keeping a high pace, however, first signs of a slowdown are on the horizon – higher volatility with respect to deals coming and going (the number of deals that A&M is engaged with is a record high, but so is the amount of deals that never start) plus the number of aborted transactions is significantly increasing.

Post-acquisition disputes sometimes arise due to different accounting standards applied. Engaging advisors prior to executing a purchase agreement is helpful to mitigate the risk of such disputes. In this edition of Raising the Bar, we discuss the situations when conflicting standards may arise and examples of disputes that might occur.

Kathleen King shares more about the Work Opportunity Tax Credit (WOTC) capability and the most common questions she receives from clients.

What investors expect out of healthcare in the rest of 2022

As global challenges continue, asset-light pharmaceutical companies will remain under increased pressure for the rest of 2022 and beyond. How can asset-light companies create value in a disrupted market? A&M shares 5-value levers for asset-light pharmaceutical businesses.